Doxorubicin Hydrochloride liposome (Janssen Products, LP)
Welcome to the PulseAid listing for the Doxorubicin Hydrochloride liposome drug offered from Janssen Products, LP. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Janssen Products, LP |
NON-PROPRIETARY NAME: | doxorubicin hydrochloride |
SUBSTANCE NAME: | DOXORUBICIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SUSPENSION, LIPOSOMAL |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-06-26 |
END MARKETING DATE: | 0000-00-00 |
Doxorubicin Hydrochloride liposome HUMAN PRESCRIPTION DRUG Details:
Item Description | Doxorubicin Hydrochloride liposome from Janssen Products, LP |
LABELER NAME: | Janssen Products, LP |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mg/mL) |
START MARKETING DATE: | 2017-06-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59676-966_2dd41244-8b08-438c-a2e1-df9e704fe8a2 |
PRODUCT NDC: | 59676-966 |
APPLICATION NUMBER: | NDA050718 |
Other DOXORUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: